Top Healthcare companies in Ireland by Debt to Equity Ratio
Ireland
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
1.55
|
Dec. 31, 2023 | USD 124.37 | -0.54% |
|
Ireland |
|
| 2 |
1.15
|
Dec. 31, 2023 | USD 2.56 | 3.17% |
|
Ireland |
|
| 3 |
0.54
|
Oct. 25, 2024 | USD 90.82 | -0.95% |
|
Ireland |
|
| 4 |
0.46
|
Sept. 30, 2024 | USD 225.44 | 2.09% |
|
Ireland |
|
| 5 |
0.43
|
Dec. 31, 2023 | USD 199.08 | -1.31% |
|
Ireland |
|
| 6 |
0.40
|
Dec. 31, 2023 | USD 7.90 | 2.73% |
|
Ireland |
|
| 7 |
0.31
|
Dec. 31, 2023 | USD 31.53 | -1.19% |
|
Ireland |
|
| 8 |
0.02
|
Dec. 31, 2023 | USD 14.23 | -3.20% |
|
Ireland |
|
| 9 |
0.00
|
Dec. 31, 2023 | USD 10.60 | 9.39% |
|
Ireland |
|
| 10 |
0.00
|
Dec. 31, 2023 | USD 70.72 | 0.21% |
|
Ireland |
|
| 11 |
-2.96
|
Dec. 31, 2023 | USD 1.60 | 1.91% |
|
Ireland |
Frequently Asked Questions
-
Which Healthcare company in Ireland has the highest Debt to Equity Ratio ?
The Healthcare company in Ireland with the highest Debt to Equity Ratio is Jazz Pharmaceuticals plc (NasdaqGS: JAZZ) at 1.55.
-
Which Healthcare company in Ireland has the lowest Debt to Equity Ratio ?
The Healthcare company in Ireland with the lowest Debt to Equity Ratio is Iterum Therapeutics plc (NasdaqCM: ITRM) at -2.96.
-
What are the top 10 Healthcare companies in Ireland by Debt to Equity Ratio ?
The top 10 Healthcare companies in Ireland by Debt to Equity Ratio are Jazz Pharmaceuticals plc, Uniphar plc, Medtronic plc, STERIS plc, ICON Public Limited Company, Avadel Pharmaceuticals plc, Alkermes plc, Prothena Corporation plc, GH Research PLC and Cosmo Pharmaceuticals N.V..
-
What are the bottom 10 Healthcare companies in Ireland by Debt to Equity Ratio ?
The bottom 10 Healthcare companies in Ireland by Debt to Equity Ratio are Iterum Therapeutics plc, Cosmo Pharmaceuticals N.V., GH Research PLC, Prothena Corporation plc, Alkermes plc, Avadel Pharmaceuticals plc, ICON Public Limited Company, STERIS plc, Medtronic plc and Uniphar plc.
